capiton, an investment company in Berlin, agreed to acquire CNP Pharma, an international manufacturer and distributor of generic pharmaceuticals. Financial terms were not disclosed. capiton acquired CNP Group from the founding family together with the management team as well as senior industry experts. Financing of the transaction is provided by capiton’s current investment vehicle, capiton VI. Additional funds have been reserved to finance both organic and inorganic growth initiatives in Germany and abroad.